KCL Therapeutics, Inc.
Records under this name other than the patents KCL Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to KCL Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,088,485 | Methods of Screening Compounds That Can Modulate NR2F6 by Displacement of a Reference Ligand Lapsed on the fee record Ended Oct 2, 2026 · High confidence | Lapsed on the fee record | Ended Oct 2, 2026 | High confidence |
| US 11,377,442 | Small Molecule Agonists and Antagonists of NR2F6 Activity Formerly held Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 11,324,719 | Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans Lapsed on the fee record Ended May 10, 2026 · High confidence | Lapsed on the fee record | Ended May 10, 2026 | High confidence |